Rissanen TH, Voutilainen S, Nyyssonen K, Salonen R, Kaplan GA, Salonen JT. Serum lycopene
concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor
Study. Am J Clin Nutr. 2003 Jan;77(1):133-8.
Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Ma J. Plasma carotenoids
and tocopherols and risk of myocardial infarction in a low-risk population of US male
physicians. Circulation. 2003 Aug 19;108(7):802-7.
Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC. Dietary carotenoids
and risk of coronary artery disease in women. Am J Clin Nutr. 2003 Jun;77(6):1390-1399.
Sesso HD, Liu S, Gaziano JM, Buring JE. Dietary lycopene, tomato-based food products and
cardiovascular disease in women. J Nutr. 2003 Jul;133(7):2336-41.
Gianetti J, Pedrinelli R, Petrucci R, Lazzerini G, De Caterina M, Bellomo G, De Caterina R.
Inverse association between carotid intima-media thickness and the antioxidant lycopene in
atherosclerosis. Am Heart J. 2002 Mar;143(3):467-74.
Chen J, He J, Hamm L, Batuman V, Whelton PK. Serum antioxidant vitamins and blood pressure
in the United States population. Hypertension. 2002 Dec;40(6):810-6.
Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X,
Drake T, Merz CN, Fogelman AM. Oxygenated carotenoid lutein and progression of early
atherosclerosis: the Los Angeles atherosclerosis study. Circulation. 2001 Jun 19;103(24):2922-7.
Gale CR, Ashurst HE, Powers HJ, Martyn CN. Antioxidant vitamin status and carotid atherosclerosis
in the elderly. Am J Clin Nutr. 2001 Sep;74(3):402-8.
Ford ES, Giles WH. Serum vitamins, carotenoids, and angina pectoris: findings from the National
Health and Nutrition Examination Survey III. Ann Epidemiol. 2000 Feb;10(2):106-16.
Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Intake of flavonoids, carotenoids,
vitamins C and E, and risk of stroke in male smokers. Stroke. 2000 Oct;31(10):2301-6.
Kohlmeier L, Kark JD, Gomez-Gracia E, Martin BC, Steck SE, Kardinaal AF, Ringstad J, Thamm M,
Masaev V, Riemersma R, Martin-Moreno JM, Huttunen JK, Kok FJ. Lycopene and myocardial infarction
risk in the EURAMIC Study. Am J Epidemiol. 1997 Oct 15;146(8):618-26.
Kristenson M, Zieden B, Kucinskiene Z, Elinder LS, Bergdahl B, Elwing B, Abaravicius A,
Razinkoviene L, Calkauskas H, Olsson AG. Antioxidant state and mortality from coronary heart
disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ.
1997 Mar 1;314(7081):629-33.
Kristal AR, Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer.
J Urol. 2004;171:S54-8
Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC. Dietary cryptoxanthin and reduced risk of lung
cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):890-8.
Giovannucci E, Rimm EB, Liu Y, Stampfer MJ and Willet WC. A prospective study of tomato products,
lycopene, and prostate cancer risk. J Natl Cancer Inst 2002; 94:391-8.
Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J,
Albanes D. Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the
alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol. 2002 Sep 15;156(6):536-47.
Cramer DW, Kuper H, Harlow BL, and Titus-Ernstoff. Carotenoids, antioxidants and ovarian cancer
risk in pre- and postmenopausal women. Int J Cancer 2001; 94:128-134.
Ngoan LT, Mizoue T, Fujino Y, Tokui N, and Yoshimura T. Dietary factors and stomach cancer
mortality. Br J Cancer 2002; 87:37-42.
Chen H, Tucker K, Graubard BI, Heineman EF, Markin S, Potischman NA, Russell RM, Weisenburger DD,
and Ward MH. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach.
Nutr Cancer 2002; 42:33-40.
McCann SE, Moysich KB, and Mettlin C. Intakes of selected nutrients and food groups and risk of
ovarian cancer. Nutr Cancer 2001; 39:19-28.
Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC. Prediagnostic levels of serum beta-cryptoxanthin and
retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomarkers
Prev. 2001 Jul;10(7):767-73.
Bertone RE, Hankinson SE, Newcomb PA, Rosner B, Willett WC, Stampfer MJ, and Egan KM. A
population-based case-control study of carotenoid and vitamin A intake and ovarian cancer
(United States). Cancer Causes Control 2001; 12:83-90.
Zeegers MP, Goldbohm RA, and van den Brandt PA. Are retinol, vitamin C, vitamin E, folate and
carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study.
Br J Cancer 2001; 28:977-983.
McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology
of endometrial cancer in Western New York (United States). Cancer Causes Control 2000;11:965-974.
Terry P, Lagergren J, Ye W, Nyrén O, and Wolk A.
Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer
2000;87:750-754.
Ekström AM, Serafini M, Nyrén O, Hansson L-E, Ye W,
and Wolk A. Dietary antioxidant intake and the risk of cardia cancer and
noncardia cancer of the intestinal and diffuse types: a population-based,
case-control study in Sweden. Int J Cancer 2000;87:133-40.
Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E. Intake of specific
carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr. 2000 Oct;72(4):990-7.
Richer S, Stiles W, Statkute L, Pulido J, Frankowski J,
Rudy D, Pei K, Tsipursky M, Nyland J. Double-masked, placebo-controlled, randomized
trial of lutein and antioxidant supplementation in the intervention of atrophic
age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant
Supplementation Trial).
Optometry. 2004 Apr;75(4):216-30.
Sies H, Stahl W, Polidori MC. Oxidative Stress: antioxidants
in degenerative neurological and ophthalmological disorders. In: Genetic
Expression and Nutrition. Bachmann C, Koletzko B (Eds.). Nestlé Nutrition Workshop Series,
Pediatric Program, Vol. 50. Nestec Ltd., Vevey/Lippincott Williams & Wilkins,
Philadelphia, 2003, pp 107-18.
Landrum JT, Bone RA, Herrero C. Astaxanthin, ß-cryptoxanthin,
lutein, and zeaxanthin. IN: Meskin MS et al, eds. Phytochemicals in Nutrition
and Health. Boca Raton: CRC, 2002, pp 173-91.
Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE.
A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women.
Am J Clin Nutr. 1999 Oct;70(4):509-16.
Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, Spiegelman D, Willett WC, Hankinson SE.
A prospective study of carotenoid intake and risk of cataract extraction in US men.
Am J Clin Nutr. 1999 Oct;70(4):517-24.
Harik-Khan RI, Muller DC, Wise RA. Serum vitamin levels and the risk of asthma in children.Am J Epidemiol.
2004 Feb 15;159(4):351-7.
Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, Klocke RA, Trevisan M. The relation
of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the
general population. Am J Respir Crit Care Med. 2001 Apr;163(5):1246-55.
Mennen LI, Sapinho D, De Bree A, Arnault N, Bertrais S, Galan P, Hercberg S. Consumption of foods rich
in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr.
2004 Apr;134(4):923-6.
Sesso HD, Gaziano JM, Liu S, Buring JE. Flavonoid intake and the risk of cardiovascular disease in women.
Am J Clin Nutr. 2003 Jun;77(6):1400-8.
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid
intake and risk of chronic diseases. Am J Clin Nutr. 2002 Sep;76(3):560-8.
Hirvonen T, Pietinen P, Virtanen M, Ovaskainen ML, Hakkinen S, Albanes D, Virtamo J. Intake of flavonols
and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001 Jan;12(1):62-7.
Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort
study. BMJ. 1996 Feb 24;312(7029):478-81.
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary
heart disease: the Zutphen Elderly Study.Lancet. 1993 Oct 23;342(8878):1007-11.
Mennen LI, Sapinho D, De Bree A, Arnault N, Bertrais S, Galan P, Hercberg S. Consumption of foods rich in
flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. J Nutr. 2004
Apr;134(4):923-6.
Naasani I, Oh-Hashi F, Oh-Hara T, Feng WY, Johnston J, Chan K, Tsuruo T. Blocking telomerase by dietary
polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.
Cancer Res. 2003 Feb 15;63(4):824-30.
Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H and Salonen JT. Risk of cardiovascular disease-related
and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk
Factor Study. Arch Intern Med 2003; 163:1099-1104.
Martin S, Favot L, Matz R, Lugnier C, Andriantsitohaina R. Delphinidin inhibits endothelial cell proliferation
and cell cycle progression through a transient activation of ERK-1/-2. Biochem Pharmacol.
2003 Feb 15;65(4):669-75.
Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, La Vecchia C, Dwyer J, Trichopoulos D. Flavonoid
intake and breast cancer risk: a case--control study in Greece. Br J Cancer. 2003 Oct 6;89(7):1255-9.
Malin AS, Qi D, Shu XO, Gao YT, Friedmann JM, Jin F, Zheng W. Intake of fruits, vegetables and selected
micronutrients in relation to the risk of breast cancer. Int J Cancer. 2003 Jun 20;105(3):413-8.
Olsen A, Tjonneland A, Thomsen BL, Loft S, Stripp C, Overvad K, Moller S, Olsen JH. Fruits and vegetables
intake differentially affects estrogen receptor negative and positive breast cancer incidence rates. J Nutr.
2003 Jul;133(7):2342-7.
Singh RP, Dhanalakshmi S, Agarwal R. Phytochemicals as cell cycle modulators--a less toxic approach in halting
human cancers. Cell Cycle. 2002 May-Jun;1(3):156-61.
Rosenberg Zand RS, Jenkins DJ, Diamandis EP. Flavonoids and steroid hormone-dependent cancers. J Chromatogr B
Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):219-32.
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid
intake and risk of chronic diseases. Am J Clin Nutr. 2002 Sep;76(3):560-8.
Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast
cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44.
Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA et al. Intake of fruits and
vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001 Feb 14;285(6):769-76.
Morrow DM, Fitzsimmons PE, Chopra M, McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin:
its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001 Sep 1;480-481:269-76.
Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of
probable mechanisms of action and potential applications.Am J Clin Nutr. 2001 Oct;74(4):418-25.
Arts IC, Hollman PC, Bueno De Mesquita HB, Feskens EJ, and Kromhout D. Dietary catechins and epithelial cancer
incidence: the Zutphen elderly study. Int J Cancer 2001; 92:298-302.
Hirvonen T, Virtamo J, Korhonen P, Albanes D, and Pietinen P. Flavonol and flavone intake and the risk of cancer
in male smokers (Finland). Cancer Causes Control 2001; 12:789-796.
Gandini S, Merzenich H, Robertson C, Boyle P. Meta-analysis of studies on breast cancer risk and diet: the role
of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer. 2000 Mar;36(5):636-46.
Kasai H, Fukada S, Yamaizumi Z, Sugie S, Mori H. Action of chlorogenic acid in vegetables and fruits as an inhibitor
of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol. 2000 May;38(5):467-71.
Lampe JW. Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies.
Am J Clin Nutr. 1999 Sep;70(3 Suppl):475S-490S.
Djuric Z, Depper JB, Uhley V, Smith D, Lababidi S, Martino S, Heilbrun LK. Oxidative DNA damage levels in blood
from women at high risk for breast cancer are associated with dietary intakes of meats, vegetables, and fruits.
J Am Diet Assoc. 1998 May;98(5):524-8.
Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc. 1996; 96:1027-1039.
Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T, Graham S. Premenopausal
breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst.
1996 Mar 20;88(6):340-8.
Woods RK, Walters EH, Raven JM, Wolfe R, Ireland PD, Thien FC, Abramson MJ. Food and nutrient intakes and asthma
risk in young adults. Am J Clin Nutr. 2003 Sep;78(3):414-21.
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake
and risk of chronic diseases. Am J Clin Nutr. 2002 Sep;76(3):560-8.
Shaheen SO, Sterne JA, Thompson RL, Songhurst CE, Margetts BM, and Burney PG. Dietary antioxidants and asthma in
adults: a population-based case-control study. Am J Respir Crit Care Med 2001; 1823-1828.
Narayana KR, Reddy MS, Chaluvadi MR, Krishna DR. Bioflavonoids classification, pharmacological, biochemical, and
therapeutic potential. Indian J Pharmacol 2001; 33:2-16
Lopez-Lazaro M, Martin-Cordero C, Toro MV, Ayuso MJ. Flavonoids as DNA topoisomerase I poisons. J Enzyme Inhib
Med Chem. 2002 Feb;17(1):25-9.
Ong KC, Khoo HE. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci.
2000 Aug 25;67(14):1695-705.
Hiermann A, Schramm HW, Laufer S. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related
compounds. Inflamm Res. 1998 Nov;47(11):421-7.
Mertens-Talcott SU, Talcott ST, Percival SS. Low concentrations of quercetin and ellagic acid synergistically
influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr. 2003 Aug;133(8):2669-74.
van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM. Biphasic modulation of cell
proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett. 2003 Oct 8;200(1):41-7.
Sampson L, Rimm E, Hollman PC, de Vries JH, Katan MB. Flavonol and flavone intakes in US health professionals.
J Am Diet Assoc. 2002 Oct;102(10):1414-20.
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake
and risk of chronic diseases. Am J Clin Nutr. 2002 Sep;76(3):560-8.
Dubick MA. Wine polyphenols and protection from atherosclerosis and ischemic heart disease: drink to your health?
IN: Meskin MS et al, eds. Phytochemicals in Nutrition and Health. Boca Raton: CRC, 2002, pp 41-60.
Morrow DM, Fitzsimmons PE, Chopra M, McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin:
its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001 Sep 1;480-481:269-76.
Anon. Quercetin. Alt Med Rev 1998; 3(2):14-143.
Leake DS. The possible role of antioxidants in fruit and vegetables in protecting against coronary artery disease.
IN: Tomas- Barberan FA, Robins RJ (Eds). Phytochemistry of Fruit and Vegetables. New York: Oxford University Press,
1997, pp. 287-311.
Hertog MGL, Van Peppel G, Verhoeven D. Potentially anticarcinogenic secondary metabolites from fruits and vegetables.
IN: Tomas- Barberan FA, Robins RJ (Eds). Phytochemistry of Fruit and Vegetables. New York: Oxford University Press,
1997, pp. 313-329.
Birt DF, Wang W, Paiva N, Au A, Chung C, Schmitt L, Jiang Y. Cancer prevention by phytochemicals, modulation of
cell cycle. IN: Meskin MS et al. (eds). Phytochemicals: Mechanisms of Action. Boca Raton: CRC, 2003 pp. 61-77.
Lin J. Cancer chemoprevention by phytopolyphenols including flavonoids and flavonoids through modulating signal
transduction pathways. IN: Meskin MS et al. (eds). Phytochemicals: Mechanisms of Action. Boca Raton: CRC, 2003 pp. 79-106.
Hendrich S, Wang G, Lin H, Xu X, Tew B, Wang H, Murphy PA. Isoflavone metabolism and bioavailability. IN: Papas AM
(Ed). Antioxidant Status, Diet, Nutrition, and Health. Boca Raton: CRC, 1999, pp 211-230.
Ueda H, Yamazaki C, Yamazaki M. A hydroxyl group of flavonoids affects oral anti-inflammatory activity and
inhibition of systemic tumor necrosis factor-alpha production. Biosci Biotechnol Biochem. 2004 Jan;68(1):119-25.
Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell
context. Environ Health Perspect. 2003 Dec;111(16):1877-82.
Das M, Ram A, Ghosh B. Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice.
Inflamm Res. 2003 Mar;52(3):101-6.
Andrikopoulos NK, Kaliora AC, Assimopoulou AN, Papageorgiou VP. Inhibitory activity of minor polyphenolic and
nonpolyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation. J Med Food. 2002 Spring;5(1):1-7.
Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T, Kinae N. Deglucuronidation of a flavonoid, luteolin monoglucuronide,
during inflammation. Drug Metab Dispos. 2001 Dec;29:1521-4.
Shimoi K, Saka N, Kaji K, Nozawa R, Kinae N. Metabolic fate of luteolin and its functional activity at focal site.
Biofactors. 2000;12(1-4):181-6.
Kim JS, Kwon CS, Son KH. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol
Biochem. 2000 Nov;64(11):2458-61.
Rotelli AE, Guardia T, Juarez AO, de la Rocha NE, Pelzer LE. Comparative study of flavonoids in experimental
models of inflammation. Pharmacol Res. 2003 Dec;48(6):601-6.
Ohtsuki K, Abe A, Mitsuzuwi H, Kondo M, Uemura K, Iwasaki Y, Kondo Y. Effects of long-term administration of
hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2002 Oct;48(5):420-2.
Olszanecki R, Gebska A, Kozlovski VI, Gryglewski RJ. Flavonoids and nitric oxide synthase.J Physiol Pharmacol.
2002 Dec;53(4 Pt 1):571-84.
Kurowska EM, Manthey JA. Regulation of lipoprotein metabolism in HepG2 cells by citrus flavonoids. Adv Exp
Med Biol. 2002;505:173-9.
Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation 2000;7(6 Pt 2):S29-34
Bugianesi R, Catasta G, Spigno P, D'Uva A, Maiani G. Naringenin from cooked tomato paste is bioavailable in
men. J Nutr. 2002 Nov;132(11):3349-52.
Ho PC, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins
and related compounds. J Pharm Pharm Sci. 2001 Sep-Dec;4(3):217-27.
Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR. Dietary catechins and cancer incidence among postmenopausal
women: the Iowa Women's Health Study (United States). Cancer Causes Control. 2002 May;13(4):373-82.
Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial
infarction. Circulation. 2002 May 28;105(21):2476-81.
McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr. 2002 Feb;21(1):1-13.
Arts IC, Jacobs DR Jr, Harnack LJ, Gross M, Folsom AR. Dietary catechins in relation to coronary heart disease
death among postmenopausal women. Epidemiology. 2001 Nov;12(6):668-75.
Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study.
Am J Respir Crit Care Med. 2001 Jul 1;164(1):61-4.
Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. Effects of cocoa powder and dark
chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans.
Am J Clin Nutr. 2001 Nov;74(5):596-602.
Riemersma RA, Rice-Evans CA, Tyrrell RM, Clifford MN, Lean ME. Tea flavonoids and cardiovascular health.
QJM. 2001 May;94(5):277-82.
Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Short- and long-term black
tea consumption reverses endothelial dysfunction in patients with coronary artery disease.
Circulation. 2001 Jul 10;104(2):151-6.
Trichopoulou A, Lagiou P, Papas AM. Mediterranean diet: are antioxidants central to its benefits?
IN: Papas AM (Ed). Antioxidant Status, Diet, Nutrition, and Health. Boca Raton: CRC, 1999, pp. 107-118.
Leake DS. The possible role of antioxidants in fruit and vegetables in protecting against coronary
artery disease. IN: Tomas- Barberan FA, Robins RJ (Eds). Phytochemistry of Fruit and Vegetables.
New York: Oxford University Press, 1997, pp. 287-311.
Prior R. Absorption and metabolism of anthocyanins: potential health effects. IN: Phytochemicals:
Mechanisms of Action. Boca Raton: CRC, 2003 pp. 1-19.
Camire ME. Phytochemicals in the Vaccinium family: bilberries, blueberries, and cranberries.
IN: Meskin MS et al, eds. Phytochemicals in Nutrition and Health. Boca Raton: CRC, 2002, pp 19-40.
Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ.
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.
Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L774-83
Lin JK & Tsai SH. Chemoprevention of cancer and
cardiovascular disease by resveratrol.
Proc Natl Sci Counc ROC(B) 1999;23(3):99-106.
Folt JD. Antithrombobotic potential of grape juice and red wine for preventing heart attacks
(human studies). Pharm Biol 1998;36:21-27.
Steinberg F, Bearden MM, Keen CL. Cocoa and chocolate flavonoids: Implications for cardiovascular health.
J Am Diet Assoc 2003;103:215-23.
Howell AB. Cranberry proanthocyanidins and the maintenenace of urinary tract health. Crit Rev Food Sci Nutr.
2002;42(3 Suppl):273-8.
Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health. Crit Rev Food Sci Nutr. 2002;42(3 Suppl):301-316.
Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG. Free radicals and grape seed
proanthocyanidin extract: importance in human health and disease prevention. Toxicology 2000;148(2-3);187-97.
Scalbert A, Deprez S, Mila I, Albrecht AM, Huneau JF, Rabot S. Proanthocyanidins and human health: systemic
effects and local effects in the gut. Biofactors 2000;13;115-120.
Thomson CA, Green TL. Cruciferous vegetables and cancer prevention. In: Watson RR, ed. Functional Foods and
Nutraceuticals in Cancer Prevention. Ames, IA Iowa State Press;2003;55-86.
Talalay P & Fahey JW. Phytochemicals from cruciferous
plants protect against cancer by modulating carcinogen metabolism. J Nutr.
2001;131:3027S-33S.
Manach C, Williamson G, Morand C, Scalbert A, and Remesy C. Bioavailability and bioefficacy of polyphenols in
humans: I-a review of 97 bioavailability studies. Am J Clin Nutr. 80s, 2004, in press.
Williamson G, and Manach C. Bioavailability and bioefficacy studies of polyphenols in humans. II. Review of
93 intervention studies. Am J Clin Nutr. 80s, 2004, in press.
Position of the American Dietetic Association: Functional Foods. J Am Diet Assoc. 2004;104:814-26.
Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals.
Am J Clin Nutr 2003 Sep;78(3 Suppl):517S-20S.
Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr 2003 Sep;78(3 Suppl)544S-51S.
Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive
compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002;113(9B):71S-88S.
